Prolonged exposure of cancer cells to IFN-γ signaling leads to expression of a number of ligands for T-cell inhibition, which in turn leads to resistance to ICIs independent of the PD-1/PD-L1-pathway [179]. This evidence concerns the gene CD274 and cancer.